NMTC
NEUROONE MEDICAL TECHNOLOGIES CorpCompany with tickers: NMTC
CIK
1500198
CUSIP
64130M209
Shares Outstanding
8,619,876
13F Activity (30d)
21 filings
21 filers
| Line Item | Value | Unit | Period End | Form | Filed |
|---|---|---|---|---|---|
| Revenue | $4,660,717 | USD | 2025-03-31 | 10-Q | 2026-05-12 |
| Revenue (ASC 606) | — | ||||
| Cost of Revenue | $1,962,767 | USD | 2025-03-31 | 10-Q | 2026-05-12 |
| Gross Profit | $2,697,950 | USD | 2025-03-31 | 10-Q | 2026-05-12 |
| Operating Expenses | $6,666,759 | USD | 2025-03-31 | 10-Q | 2026-05-12 |
| Research & Development | $2,682,891 | USD | 2025-03-31 | 10-Q | 2026-05-12 |
| Operating Income | $-968,809 | USD | 2025-03-31 | 10-Q | 2026-05-12 |
| Net Income | $1,785,322 | USD | 2024-12-31 | 10-Q | 2026-05-12 |
| EPS (Basic) | $-0.09 | USD/shares | 2025-03-31 | 10-Q | 2026-05-12 |
| EPS (Diluted) | $-0.09 | USD/shares | 2025-03-31 | 10-Q | 2026-05-12 |